Publications

5674 Results

Vitamin D metabolic pathway genes and pancreatic cancer risk

Authors
H Arem;D Maeder;K Yu;X Xiong;K Moy;N Freedman;ST Mayne;D Albanes;AA Arslan;M Austin;WR Bamlet;L Beane-Freeman;P Bracchi;F Canzian;M Cotterchio;EJ Duell;S Gallinger;GG Giles;M Goggins;P Goodman;P Hartge;M Hassan;K Helzlsouer;B Henderson;E Holly;R Hoover;E Jacobs;A Kamineni;A Klein;E Klein;L Kolonel;D Li;S Mannisto;M McCullough;S Olson;I Orlow;U Peters;G Peetersen;P Real;F Severi;XO Shu;K Visvanathan;E White;H Yu;A Zeleniuch-Jacquotte;W Zheng;H Risch;J Sampson;R Stolzenberg-Solomon
Journal / Conference
PLOS ONE 10(3):e0117574
Year
2015
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID25799011
PMC
PMC4370655
Study Number(s)
S0000

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II-III triple-negative breast cancer: CALGB 40603 (Alliance)

Authors
WM Sikov;DA Berry;CM Perou;B Singh;CT Cirrincione;SM Tolaney;CS Kuzma;TJ Pluard;G Somlo;ER Port;M Golshan;JR Bellon;D Collyar;OM Hahn;LA Carey;C Hudis;E Winer
Journal / Conference
Journal of Clinical Oncology 33(1):13-21
Year
2015
Research Committee(s)
Breast
PMID
PMID25092775
PMC
PMC4268249
Study Number(s)
CTSU/C40603

Prospective study of human herpes virus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Authors
S Sutcliffe;C Till;FJ Jenkins;C Gaydos;P Goodman;A Hoque;A Hsing;IM Thompson;WG Nelson;A De Marzo;E Platz
Journal / Conference
Cancer Causes and Control 26(1):35-44
Year
2015
Research Committee(s)
Cancer Control
PMID
PMID25359302
PMC
PMC4282945
Study Number(s)
SWOG-9217

A pilot trial of cisplatin/etoposide/radiotherapy followed by consolidation docetaxel and the addition of bevacizumab (NSC-704865) in patients with inoperable locally advanced stage III non-small cell lung cancer: SWOG S0533

Authors
A Wozniak;J Moon;CR Thomas;K Kelly;PC Mack;L Gaspar;D Raben;TJ Fitzgerald;KJ Pandya;DR Gandara
Journal / Conference
Clinical Lung Cancer Sep;16(5):340-347
Year
2015
Research Committee(s)
Lung
PMID
PMID25703100
PMC
PMC4497941
Study Number(s)
S0533

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Authors
H Moore;J Unger;KA Phillips;F Boyle;E Hitre;D Porter;P Francis;L Goldstein;H Gomez;C Vallejos;A Partridge;S Dhakil;A Garcia;J Gralow;J Lombard;J Forbes;S Martino;W Barlow;C Fabian;L Minasian;F Meyskens;R Gelber;G Hortobagyi;K Albain
Journal / Conference
New England Journal of Medicine, Mar 5; 372(10):923-932
Year
2015
Research Committee(s)
Breast
PMID
PMID25738668
PMC
PMC4405231
Study Number(s)
S0230

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Authors
K Ng;J Meyerhardt;J Chan;D Niedzwiecki;L Saltz;R Mayer;A Benson;P Schaefer;R Whittom;A Hantel;R Goldberg;A Venook;S Ogino;E Giovannucci;C Fuchs
Journal / Conference
Journal of the National Cancer Institute, 2014 Nov 27;107(1):345. doi: 10.1093/jnci/dju345; Print Jan 2015 Jan
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25432409
PMC
PMC4271076
Study Number(s)
C89803

Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stage I or II locally extensive, bulky mediastinal hodgkins lymphoma: a subset analysis of the North American Intergroup E2496 trial

Authors
R Advani;F Hong;RI Fisher;N Bartlett;S Robinson;R Gascoyne;H Wagner;P Stiff;B Cheson;D Stewart;LI Gordon;B Kahl;J Friedberg;KA Blum;TM Habermann;J Tuscano;RT Hoppe;SJ Horning
Journal / Conference
Journal of Clinical Oncology Jun 10;33(17):1936-1942
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25897153
PMC
PMC4451176
Study Number(s)
E2496

Elevated serum levels of IL-2R, IL-1RA and CXCL9 are associated with a poor prognosis in follicular lymphoma

Authors
M Mir;MJ Mauer;SC Ziesmer;S Slager;T Habermann;W Macon;BK Link;S Syrbu;T Witzig;J Friedberg;O Press;M Leblanc;J Cerhan;A Novak;S Ansell
Journal / Conference
Blood Feb 5;125(6):992-998
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25422100
PMC
PMC4319239
Study Number(s)
S0016, S9800, S9911

SWOG S0925: A randomized phase 2 study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer

Authors
E Yu;H Li;C Higano;N Agarwal;SK Pal;A Alva;E Heath;E Lam;S Gupta;M Lilly;Y Inoue;K Chi;N Vogelzang;DI Quinn;H Cheng;SR Plymate;M Hussain;C Tangen;IM Thompson
Journal / Conference
Journal of Clinical Oncology May 10;33(14):1601-1608
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID25847934
PMC
PMC4417730
Study Number(s)
S0925

SWOG S9005: double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma

Authors
Y Ji;C Rankin;S Grunberg;J Ahmadi;J Townsend;L Feun;R Fredericks;CA Russell;F Kabbinavar;KJ Stelzer;A Schott;C Verschraegen
Journal / Conference
Journal of Clinical Oncology Dec 1;33(34):4093-4098
Year
2015
Research Committee(s)
Brain
PMID
PMID26527781
PMC
PMC4669593
Study Number(s)
SWOG-9005